The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies

Research output: Contribution to conference (unpublished) › Abstract

Standard

The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies. / Frew, Emma; Sandercock, Josie; Whitehouse, W; Bryan, Stirling.

2005.

Research output: Contribution to conference (unpublished) › Abstract

Harvard

Frew, E, Sandercock, J, Whitehouse, W & Bryan, S 2005, 'The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies'.

APA

Frew, E., Sandercock, J., Whitehouse, W., & Bryan, S. (2005). The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies.

Vancouver

Frew E, Sandercock J, Whitehouse W, Bryan S. The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies. 2005.

Author

Frew, Emma ; Sandercock, Josie ; Whitehouse, W ; Bryan, Stirling. / The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies.

Bibtex

@conference{fd4eb4317a9747c4a6cfe96f5cb2e666,
title = "The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies",
author = "Emma Frew and Josie Sandercock and W Whitehouse and Stirling Bryan",
year = "2005",
month = jul,
day = "31",
language = "English",

}

RIS

TY - CONF

T1 - The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies

AU - Frew, Emma

AU - Sandercock, Josie

AU - Whitehouse, W

AU - Bryan, Stirling

PY - 2005/7/31

Y1 - 2005/7/31

M3 - Abstract

ER -